SHELLEY THUNEN
CO-PRESIDENT/CFO
RXSIGHT INC.
WHY: Became CFO of RxSight, Aliso Viejo-based maker of intraocular, in February 2017. Earned bachelor’s in economics and MBA from UCI in November 2023. Serves as board member and audit committee chair of Lenz Therapeutics, Aeon Biopharma and Surface Ophthalmics.
IN THE NEWS: Confirms there are no competitors as of late with RxSight’s technology. The company saw 234% growth in revenue in last two years.
QUOTABLE: “We’re used to competing against much larger players because we have something unique in the marketplace.”
